Granisetron is an anti-nausea medicine used to prevent nausea and vomiting caused by chemotherapy and, in some cases, radiation therapy. This guide covers granisetron uses, how it works, dosage, side effects, precautions, drug interactions, use in pregnancy and breastfeeding and brand names.
At a Glance
|
|
Medicine class: | serotonin 5-HT3 receptor antagonist (antiemetic). It is a prescription medicine. |
Main use: | preventing nausea and vomiting caused by chemotherapy and radiation therapy. Some injection and tablet labels also include nausea and vomiting after surgery (PONV) in adults. |
Forms: | tablets and injection. They are different products with different labelled uses and doses. |
Key safety points: | tell your doctor about heart rhythm problems, and about antidepressants or other medicines that raise serotonin levels. |
Pregnancy and breastfeeding: | the treating healthcare professional weighs benefit and risk, because data in humans are limited. |
Note on labels: | dosing and approved uses below are based on U.S. prescribing information unless another country is named. Labels in India and other countries may differ, so follow the label of the product you are given. |
What is Granisetron?
Granisetron is a serotonin 5-HT3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). It helps control these symptoms. It is not a chemotherapy medicine and it does not treat cancer.
How Granisetron Works
During chemotherapy and radiation, cells in the gut lining release serotonin. Serotonin stimulates 5-HT3 receptors on the vagus nerve in the gut and in the vomiting trigger area of the brain, and this signal can set off nausea and vomiting. Granisetron blocks these receptors, so the signal is blocked and nausea, vomiting and retching are less likely.
When Granisetron Is Used
- Chemotherapy: the injection and the tablets are used to prevent nausea and vomiting with first and repeat courses of chemotherapy, including high-dose cisplatin.
- Radiation therapy: the tablets are labelled in the U.S. to prevent nausea and vomiting with radiation, including total body irradiation and radiation to the abdomen.
- After surgery (PONV): in some formulations and countries, granisetron is also used in adults for prevention or treatment of postoperative nausea and vomiting. In the U.S., this use appears on some injection labels and not on others, and the U.S. tablet label does not list it. The UK labels for both tablets and injection list PONV in adults. Follow the local product label and your healthcare professional’s instructions.
- Motion sickness is not listed as an indication in the U.S. or UK product labels.
Granisetron Dosage and How It Is Given
Dosage depends on the product (injection or tablet), the reason it is used, age, and the treatment protocol. The doses below come from U.S. prescribing information for adults. Labels in other countries may use different regimens, including fixed milligram doses instead of weight-based doses.
- Injection for chemotherapy (adults): given into a vein by a healthcare professional. The U.S. label dose is 10 mcg per kg of body weight, within 30 minutes before chemotherapy starts, and only on the day or days chemotherapy is given.
- Injection for PONV (adults, where the label includes this use): the U.S. label dose is 1 mg given into a vein. For prevention it is given before anesthesia starts or just before anesthesia is reversed, and for treatment it is given after nausea or vomiting occurs.
- Tablets for chemotherapy (adults): the U.S. label dose is 2 mg once a day, or 1 mg twice a day. The first dose is taken up to 1 hour before chemotherapy, and the second dose of the twice-daily plan is taken 12 hours later. Either plan is used only on chemotherapy days. Continued use on days without chemotherapy has not been found to be useful.
- Tablets for radiation therapy (adults): the U.S. label dose is 2 mg once a day, taken within 1 hour before radiation.
- For prevention of chemotherapy-induced nausea and vomiting, granisetron is generally given before treatment, so that it is already working when nausea would begin.
- Children: dosing in children is weight-based and must be decided by the treating medical team. It should never be calculated at home.
- Kidney, liver and age: the U.S. labels for both the injection and the tablets do not recommend a dose change for older adults or for people with kidney or liver impairment. This statement comes from those labels and may not apply to every product in every country.
- Take this medicine only as advised by your doctor or healthcare professional. Do not start, stop, or change the dose on your own.
Side Effects of Granisetron
- Common side effects reported in the U.S. labels include headache, constipation, weakness or tiredness, diarrhea, stomach pain, indigestion, dizziness, trouble sleeping and fever. Constipation can happen partly because granisetron may slow the movement of food through the colon. After surgery use, blood tests may show raised liver enzymes.
Get urgent medical help if you have:
- Signs of a serious allergic reaction, such as hives, trouble breathing, swelling of the face, lips or throat, or a sudden drop in blood pressure.
- A fast, irregular or pounding heartbeat, or fainting. Granisetron can affect heart rhythm (QT prolongation).
- Signs of serotonin syndrome, such as agitation, hallucinations, confusion, fast heartbeat, fever, sweating, shaking, muscle stiffness or twitching. Serotonin syndrome has been reported with this class of medicines, mostly when used with other serotonin-raising medicines.
- Also tell your doctor promptly about severe stomach pain or swelling of the abdomen.
Granisetron Precautions and Monitoring
- Granisetron should not be used by people with known hypersensitivity to it or to any of its ingredients. People who have had an allergic reaction to other medicines of the same class may also react to granisetron.
- Heart rhythm: an adequate QT study has not been done, but QT prolongation has been reported. Caution is advised in people with existing heart rhythm or conduction problems. The risk may be higher with heart disease, certain chemotherapy medicines that can affect the heart, low electrolyte levels, or medicines that prolong the QT interval. Your doctor may monitor for heart rhythm changes and for signs of serotonin syndrome.
- Gut movement: granisetron does not stimulate movement of the stomach or intestines, and it should not be used instead of nasogastric suction (a tube that drains the stomach). Because it reduces vomiting, it may hide the signs of a worsening ileus (a slowed or blocked bowel) or stomach swelling, especially after abdominal surgery or during chemotherapy. Report severe belly pain, bloating or swelling right away.
- Children: the U.S. injection label does not recommend use for postoperative nausea and vomiting in children, because a trial showed no proven benefit and QT prolongation.
Granisetron Drug Interactions
- Serotonin-raising medicines: serotonin syndrome has been reported with 5-HT3 blockers, mostly with other serotonergic medicines. The U.S. labels name SSRIs, SNRIs, MAO inhibitors, mirtazapine, fentanyl, lithium, tramadol and intravenous methylene blue. The use of these together may increase the risk, so your doctor will decide if the combination is appropriate.
- QT-prolonging medicines: using granisetron with medicines known to prolong the QT interval or affect heart rhythm may have clinical consequences.
- Liver enzyme inducers or inhibitors: granisetron is broken down by liver enzymes, so medicines that speed up or slow these enzymes may change how quickly it leaves the body. The clinical importance of this is not known.
- In the U.S. labels, granisetron was used safely with benzodiazepines, neuroleptics and anti-ulcer medicines, and it does not appear to interact with commonly used chemotherapy medicines.
- Tell your doctor or pharmacist about all prescription medicines, over-the-counter medicines, supplements and herbal products you use. This list is not complete.
Granisetron in Pregnancy and Breastfeeding
- Pregnancy: studies in pregnant rats and rabbits did not show harm to the baby, but animal studies do not always predict human results, and there are no adequate, well-controlled studies in pregnant women. The U.S. labels advise using granisetron in pregnancy only if clearly needed. Whether it is right for you is a decision for your doctor, who weighs the benefit against the possible risk.
- Breastfeeding: it is not known whether granisetron passes into human milk, and its effects on a nursing baby and on milk production are not known. The U.S. labels advise caution, and a lactation reference (LactMed) suggests that an alternate medicine may be preferred. Please discuss breastfeeding with your healthcare professional before treatment.
Granisetron Brands and Strengths Available in India
Indian online pharmacy listings show granisetron brands such as Granicip (Cipla), Graniset (Sun Pharma) and Graniforce (Mankind). Tablets are listed as 1 mg, and some brands are dispersible (DT) tablets. Injections are listed as 1 mg per mL, commonly in 3 mL vials (3 mg in 3 mL). Brand availability and product details can change, so confirm with your pharmacist and follow the label of the product you are given.
How HealthPil Can Help
Medicines should be started, adjusted, or stopped only under the guidance of a qualified healthcare professional. If you have questions about granisetron, its side effects, or your chemotherapy treatment plan, you can consult a doctor through HealthPil. HealthPil provides access to oncologists and anesthesiologists for proper management of chemotherapy side effects.
FAQ
Can Granisetron be used for motion sickness?
No, Granisetron is specifically used for nausea related to chemotherapy and surgery.
Is Granisetron safe for children?
Yes, but the dosage should be carefully adjusted based on the child’s weight.
How soon does Granisetron start working?
Granisetron typically begins to work within an hour of administration.
References
Drugs.com. Granisetron. Available at:
Drugs.comNHS Business Services Authority. Granisetron. Available at:
NHSAapro et al. Granisetron: a review of its pharmacological properties and therapeutic use in the management of nausea and vomiting. Available at:
PubMed
Disclaimer
Granisetron should be used as prescribed by your doctor. HealthPil provides access to oncologists and anesthesiologists for proper management of chemotherapy side effects.
Read our editorial policy